Kymera Therapeutics
KYMR
KYMR
157 hedge funds and large institutions have $2.01B invested in Kymera Therapeutics in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
-7
Holders Change %
-4.27%
% of All Funds
2.28%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
25
Increased
59
Reduced
49
Closed
30
Calls
$961K
Puts
$698K
Net Calls
+$263K
Net Calls Change
-$1.72M
Top Buyers
| 1 |
BlackRock
New York
|
$124M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$144M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
$13.8M |
| 4 |
UBS AM
Chicago,
Illinois
|
$12.9M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
$44.8M |
